CHRONOVAX

Serial Number 75372482
606

Registration Progress

Application Filed
Oct 14, 1997
Under Examination
Dec 8, 1998
Approved for Publication
Aug 14, 1998
Published for Opposition
Sep 15, 1998
Registered

Trademark Image

CHRONOVAX

Basic Information

Serial Number
75372482
Filing Date
October 14, 1997
Published for Opposition
September 15, 1998
Abandonment Date
May 18, 2002
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 9, 2001
Classes
005

Rights Holder

BIOSOURCE TECHNOLOGIES, INC.

03
Address
3333 Vaca Valley Parkway
Vacaville, CA 95688

Ownership History

BIOSOURCE TECHNOLOGIES, INC.

Original Applicant
03
Vacaville, CA

BIOSOURCE TECHNOLOGIES, INC.

Owner at Publication
03
Vacaville, CA

Legal Representation

Attorney
Daniel R. Gropper

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

17 events
Date Code Type Description Documents
May 18, 2002 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 11, 2001 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 30, 2001 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 11, 2001 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 3, 2000 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 5, 2000 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 11, 2000 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 9, 1999 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 8, 1999 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 20, 1999 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 26, 1999 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 8, 1998 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 15, 1998 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 14, 1998 NPUB O NOTICE OF PUBLICATION Loading...
Jul 6, 1998 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 18, 1998 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 3, 1998 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER; IMMUNOTHERAPY VACCINES FOR THE TREATMENT OF CANCER
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005